General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
27-Nov-2024 19:12:22
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG241127OTHRCB3Q
Submitted By (Co./ Ind. Name)
Akhilesh Nand - Biocon Biologics Limited
Designation
Company Secretary
Effective Date and Time of the event
27/11/2024 17:00:00
Description (Please provide a detailed description of the event in the box below)
Press release titled Biocon Biologics Supports Diabetes Africa to Drive Progress in Embedding Specialist Nurses in Diabetes Care in Ethiopia

Attachments

BBL_PR_SGX_27112024.pdf
Total size =445K